Form 4: Bicycle Therapeutics CFO Sells Shares
Insider Transaction Filing
Bicycle Therapeutics PLC reports a Form 4 filing detailing stock transactions by Chief Financial Officer Travis Alvin Thompson.
Summary
- Travis Alvin Thompson, Chief Financial Officer of Bicycle Therapeutics PLC, reported transactions involving ordinary shares.
- On July 2, 2026, 819 ordinary shares were sold at a weighted average price of $4.27 to cover tax withholding obligations related to RSU vesting.
- On July 6, 2026, 104 ordinary shares were sold at a weighted average price of $4.31, also to cover tax withholding obligations.
- Following these transactions, Mr. Thompson beneficially owns 64,545 ordinary shares directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as the reported stock sales were mandatory for tax withholding and not discretionary.
Negatives
- The Chief Financial Officer sold company stock, which could be perceived negatively by the market, although the sales were mandated for tax withholding.
Future Outlook
No specific future outlook or guidance is provided in this Form 4 filing.
Management Comments
- The sale of shares was mandated by the Reporting Person's award agreement to satisfy minimum statutory tax withholding obligations through a 'sell to cover' transaction.
- This sale does not represent a discretionary sale by the Reporting Person.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. While sales by executives can sometimes signal concerns, the explanation provided here indicates these were non-discretionary sales to cover tax liabilities arising from RSU vesting, a common occurrence.
Stakeholder Impact
- Shareholders may note the sale of shares by the CFO, but the explanation clarifies it's a non-discretionary event related to RSU vesting and tax obligations, mitigating potential negative sentiment.
Key Dates
| Date | Description |
|---|---|
| 07/02/2026 | Date of earliest transaction reported; sale of 819 ordinary shares. |
| 07/06/2026 | Date of transaction; sale of 104 ordinary shares. |
| 07/07/2026 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Insider Transaction, Stock Sale, Bicycle Therapeutics, Travis Alvin Thompson, Chief Financial Officer, RSU Vesting, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.